NCT04630223 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kucukbas GN, Kara O, Yüce D, Uygur D
Maternal plasma endocan levels in intrauterine growth restriction. J Matern Fetal Neonatal Med. 2020 Apr 14:1-6. doi: 10.1080/14767058.2020.1749591. [Epub ahead of print]
Lan X, Liu Z
Circulating endocan and preeclampsia: a meta-analysis. Biosci Rep. 2020 Jan 31;40(1). pii: BSR20193219. doi: 10.1042/BSR20193219.
Szpera-Gozdziewicz A, Kosicka K, Gozdziewicz T, Krzyscin M, Wirstlein P, Siemiatkowska A, Glowka F, Wender-Ozegowska E, Breborowicz GH
Maternal Serum Endocan Concentration in Pregnancies Complicated by Intrauterine Growth Restriction. Reprod Sci. 2019 Ma

Comparison of Umbilical Cord Blood Levels of Endocan in Pregnant Females With and Without Intrauterine Growth Retardation

Clinical trial NCT04630223 - References